Guidance on pharmacovigilance procedures in the event of a no-deal Brexit

This guidance summarises our approach to pharmacovigilance in the event of no-deal Brexit.



Stay up to date

The UK is leaving the EU. This page tells you how to prepare for Brexit and will be updated if anything changes.

Sign up for email alerts to get the latest information.

This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.

Published 18 March 2019
Last updated 9 October 2019 + show all updates
  1. Major changes to content, including two new sections (9 and 10).
  2. Change of text within Stay up to date box.
  3. First published.